0001274737-23-000091.txt : 20230906
0001274737-23-000091.hdr.sgml : 20230906
20230906170534
ACCESSION NUMBER: 0001274737-23-000091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230831
FILED AS OF DATE: 20230906
DATE AS OF CHANGE: 20230906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ABALLI JOHN
CENTRAL INDEX KEY: 0001843113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39049
FILM NUMBER: 231240002
MAIL ADDRESS:
STREET 1: C/O DECIPHER BIOSCIENCES, INC.
STREET 2: 6925 LUSK BLVD, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXAGEN INC.
CENTRAL INDEX KEY: 0001274737
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1261 LIBERTY WAY
CITY: VISTA
STATE: CA
ZIP: 92081
BUSINESS PHONE: (760) 560-1501
MAIL ADDRESS:
STREET 1: 1261 LIBERTY WAY
CITY: VISTA
STATE: CA
ZIP: 92081
FORMER COMPANY:
FORMER CONFORMED NAME: EXAGEN DIAGNOSTICS INC
DATE OF NAME CHANGE: 20031230
4
1
wk-form4_1694034315.xml
FORM 4
X0508
4
2023-08-31
0
0001274737
EXAGEN INC.
XGN
0001843113
ABALLI JOHN
C/O EXAGEN INC.
1261 LIBERTY WAY
VISTA
CA
92081
1
1
0
0
President and CEO
0
Common Stock
2023-08-31
5
A
0
E
9803
2.142
A
449803
D
Represents shares of common stock purchased through Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
/s/ Kamal Adawi, as attorney-in-fact
2023-09-06